TWiV 621: An era of COVID-19 poppycock

Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email. Hosts: Vincent Racaniello,Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler and Brianne Barker Guests: Daniel Griffin and Chuck Knirsch Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Safety of Ad5 vectored COVID-19 vaccine (Lancet) Analysis of hydroxychloroquine use (Lancet) Remdesivir study (NEJM) Ancient COVID-19 history (MMWR) Drug repurposing for COVID-19 (bioRxiv) Why do few COVID-19 patients infect others? (Science) Overdispersion in COVID-19 transmission (Wellcome Open Res) Reducing airborne transmission (Science) Letters read on TWiV 621 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees. Send your virology questions and comments to [email protected]